Cargando…
A proof of concept study of Infliximab for the treatment of HTLV-1-associated myelopathy
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044352/ http://dx.doi.org/10.1186/1742-4690-11-S1-P31 |
| _version_ | 1782319131827109888 |
|---|---|
| author | Martin, Fabiola Castro, Hannah Gabriel, Carolyn Adonis, Adine Fedina, Alexandra Harrison, Linda Brodnicki, Liz Demontis, Maria A Babiker, Abdel G Weber, Jonathan N Bangham, Charles RM Taylor, Graham P |
| author_facet | Martin, Fabiola Castro, Hannah Gabriel, Carolyn Adonis, Adine Fedina, Alexandra Harrison, Linda Brodnicki, Liz Demontis, Maria A Babiker, Abdel G Weber, Jonathan N Bangham, Charles RM Taylor, Graham P |
| author_sort | Martin, Fabiola |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4044352 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-40443522014-06-19 A proof of concept study of Infliximab for the treatment of HTLV-1-associated myelopathy Martin, Fabiola Castro, Hannah Gabriel, Carolyn Adonis, Adine Fedina, Alexandra Harrison, Linda Brodnicki, Liz Demontis, Maria A Babiker, Abdel G Weber, Jonathan N Bangham, Charles RM Taylor, Graham P Retrovirology Poster Presentation BioMed Central 2014-01-07 /pmc/articles/PMC4044352/ http://dx.doi.org/10.1186/1742-4690-11-S1-P31 Text en Copyright © 2014 Martin et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Martin, Fabiola Castro, Hannah Gabriel, Carolyn Adonis, Adine Fedina, Alexandra Harrison, Linda Brodnicki, Liz Demontis, Maria A Babiker, Abdel G Weber, Jonathan N Bangham, Charles RM Taylor, Graham P A proof of concept study of Infliximab for the treatment of HTLV-1-associated myelopathy |
| title | A proof of concept study of Infliximab for the treatment of HTLV-1-associated myelopathy |
| title_full | A proof of concept study of Infliximab for the treatment of HTLV-1-associated myelopathy |
| title_fullStr | A proof of concept study of Infliximab for the treatment of HTLV-1-associated myelopathy |
| title_full_unstemmed | A proof of concept study of Infliximab for the treatment of HTLV-1-associated myelopathy |
| title_short | A proof of concept study of Infliximab for the treatment of HTLV-1-associated myelopathy |
| title_sort | proof of concept study of infliximab for the treatment of htlv-1-associated myelopathy |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044352/ http://dx.doi.org/10.1186/1742-4690-11-S1-P31 |
| work_keys_str_mv | AT martinfabiola aproofofconceptstudyofinfliximabforthetreatmentofhtlv1associatedmyelopathy AT castrohannah aproofofconceptstudyofinfliximabforthetreatmentofhtlv1associatedmyelopathy AT gabrielcarolyn aproofofconceptstudyofinfliximabforthetreatmentofhtlv1associatedmyelopathy AT adonisadine aproofofconceptstudyofinfliximabforthetreatmentofhtlv1associatedmyelopathy AT fedinaalexandra aproofofconceptstudyofinfliximabforthetreatmentofhtlv1associatedmyelopathy AT harrisonlinda aproofofconceptstudyofinfliximabforthetreatmentofhtlv1associatedmyelopathy AT brodnickiliz aproofofconceptstudyofinfliximabforthetreatmentofhtlv1associatedmyelopathy AT demontismariaa aproofofconceptstudyofinfliximabforthetreatmentofhtlv1associatedmyelopathy AT babikerabdelg aproofofconceptstudyofinfliximabforthetreatmentofhtlv1associatedmyelopathy AT weberjonathann aproofofconceptstudyofinfliximabforthetreatmentofhtlv1associatedmyelopathy AT banghamcharlesrm aproofofconceptstudyofinfliximabforthetreatmentofhtlv1associatedmyelopathy AT taylorgrahamp aproofofconceptstudyofinfliximabforthetreatmentofhtlv1associatedmyelopathy AT martinfabiola proofofconceptstudyofinfliximabforthetreatmentofhtlv1associatedmyelopathy AT castrohannah proofofconceptstudyofinfliximabforthetreatmentofhtlv1associatedmyelopathy AT gabrielcarolyn proofofconceptstudyofinfliximabforthetreatmentofhtlv1associatedmyelopathy AT adonisadine proofofconceptstudyofinfliximabforthetreatmentofhtlv1associatedmyelopathy AT fedinaalexandra proofofconceptstudyofinfliximabforthetreatmentofhtlv1associatedmyelopathy AT harrisonlinda proofofconceptstudyofinfliximabforthetreatmentofhtlv1associatedmyelopathy AT brodnickiliz proofofconceptstudyofinfliximabforthetreatmentofhtlv1associatedmyelopathy AT demontismariaa proofofconceptstudyofinfliximabforthetreatmentofhtlv1associatedmyelopathy AT babikerabdelg proofofconceptstudyofinfliximabforthetreatmentofhtlv1associatedmyelopathy AT weberjonathann proofofconceptstudyofinfliximabforthetreatmentofhtlv1associatedmyelopathy AT banghamcharlesrm proofofconceptstudyofinfliximabforthetreatmentofhtlv1associatedmyelopathy AT taylorgrahamp proofofconceptstudyofinfliximabforthetreatmentofhtlv1associatedmyelopathy |